109 related articles for article (PubMed ID: 22292953)
1. In silico investigation of the disease-associated retinoschisin C110Y and C219G mutants.
Wu JW; Liu HL
J Biomol Struct Dyn; 2012; 29(5):937-59. PubMed ID: 22292953
[TBL] [Abstract][Full Text] [Related]
2. Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis.
Wu WW; Molday RS
J Biol Chem; 2003 Jul; 278(30):28139-46. PubMed ID: 12746437
[TBL] [Abstract][Full Text] [Related]
3. RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer.
Wu WW; Wong JP; Kast J; Molday RS
J Biol Chem; 2005 Mar; 280(11):10721-30. PubMed ID: 15644328
[TBL] [Abstract][Full Text] [Related]
4. Cog-Wheel Octameric Structure of RS1, the Discoidin Domain Containing Retinal Protein Associated with X-Linked Retinoschisis.
Bush M; Setiaputra D; Yip CK; Molday RS
PLoS One; 2016; 11(1):e0147653. PubMed ID: 26812435
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.
Vijayasarathy C; Sui R; Zeng Y; Yang G; Xu F; Caruso RC; Lewis RA; Ziccardi L; Sieving PA
Hum Mutat; 2010 Nov; 31(11):1251-60. PubMed ID: 20809529
[TBL] [Abstract][Full Text] [Related]
6. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.
Molday RS; Kellner U; Weber BH
Prog Retin Eye Res; 2012 May; 31(3):195-212. PubMed ID: 22245536
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis.
Sergeev YV; Caruso RC; Meltzer MR; Smaoui N; MacDonald IM; Sieving PA
Hum Mol Genet; 2010 Apr; 19(7):1302-13. PubMed ID: 20061330
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation.
Wang T; Zhou A; Waters CT; O'Connor E; Read RJ; Trump D
Br J Ophthalmol; 2006 Jan; 90(1):81-6. PubMed ID: 16361673
[TBL] [Abstract][Full Text] [Related]
9. Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy.
Dyka FM; Molday RS
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2491-7. PubMed ID: 17525175
[TBL] [Abstract][Full Text] [Related]
10. Characterization and purification of the discoidin domain-containing protein retinoschisin and its interaction with galactose.
Dyka FM; Wu WW; Pfeifer TA; Molday LL; Grigliatti TA; Molday RS
Biochemistry; 2008 Sep; 47(35):9098-106. PubMed ID: 18690710
[TBL] [Abstract][Full Text] [Related]
11. Understanding variable disease severity in X-linked retinoschisis: Does RS1 secretory mechanism determine disease severity?
Sudha D; Neriyanuri S; Sachidanandam R; Natarajan SN; Gandra M; Tharigopala A; Sivashanmugam M; Alameen M; Vetrivel U; Gopal L; Khetan V; Raman R; Sen P; Chidambaram S; Arunachalam JP
PLoS One; 2018; 13(5):e0198086. PubMed ID: 29851975
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of X-linked retinoschisis mutations reveals distinct classes which differentially effect retinoschisin function.
Ramsay EP; Collins RF; Owens TW; Siebert CA; Jones RPO; Wang T; Roseman AM; Baldock C
Hum Mol Genet; 2016 Dec; 25(24):5311-5320. PubMed ID: 27798099
[TBL] [Abstract][Full Text] [Related]
13. Pathomechanism of mutated and secreted retinoschisin in X-linked juvenile retinoschisis.
Plössl K; Schmid V; Straub K; Schmid C; Ammon M; Merkl R; Weber BHF; Friedrich U
Exp Eye Res; 2018 Dec; 177():23-34. PubMed ID: 30040949
[TBL] [Abstract][Full Text] [Related]
14. Advances in understanding the molecular structure of retinoschisin while questions remain of biological function.
Heymann JB; Vijayasarathy C; Fariss RN; Sieving PA
Prog Retin Eye Res; 2023 Jul; 95():101147. PubMed ID: 36402656
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling indicates distinct classes of missense variants with mild and severe XLRS phenotypes.
Sergeev YV; Vitale S; Sieving PA; Vincent A; Robson AG; Moore AT; Webster AR; Holder GE
Hum Mol Genet; 2013 Dec; 22(23):4756-67. PubMed ID: 23847049
[TBL] [Abstract][Full Text] [Related]
16. Effects of pathological mutations on the stability of a conserved amino acid triad in retinoschisin.
Fraternali F; Cavallo L; Musco G
FEBS Lett; 2003 Jun; 544(1-3):21-6. PubMed ID: 12782284
[TBL] [Abstract][Full Text] [Related]
17. Intracellular retention of mutant retinoschisin is the pathological mechanism underlying X-linked retinoschisis.
Wang T; Waters CT; Rothman AM; Jakins TJ; Römisch K; Trump D
Hum Mol Genet; 2002 Nov; 11(24):3097-105. PubMed ID: 12417531
[TBL] [Abstract][Full Text] [Related]
18. The X-linked juvenile retinoschisis protein retinoschisin is a novel regulator of mitogen-activated protein kinase signalling and apoptosis in the retina.
Plössl K; Weber BH; Friedrich U
J Cell Mol Med; 2017 Apr; 21(4):768-780. PubMed ID: 27995734
[TBL] [Abstract][Full Text] [Related]
19. Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex.
Molday LL; Wu WW; Molday RS
J Biol Chem; 2007 Nov; 282(45):32792-801. PubMed ID: 17804407
[TBL] [Abstract][Full Text] [Related]
20. Paired octamer rings of retinoschisin suggest a junctional model for cell-cell adhesion in the retina.
Tolun G; Vijayasarathy C; Huang R; Zeng Y; Li Y; Steven AC; Sieving PA; Heymann JB
Proc Natl Acad Sci U S A; 2016 May; 113(19):5287-92. PubMed ID: 27114531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
